ASP Isotopes Given "Buy" Rating by Canaccord Genuity
Apr 14, 2026
Canaccord Genuity reiterated a Buy rating on ASP Isotopes with an $11 price target, citing strong revenue growth despite missed EPS estimates for its medical isotope production.
Show all 124 updates